Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Getz

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Therapeutic Innovation & Regulatory Science|September 1, 2020
Establishing Consensus Understanding of the Barriers to Drug Development in LupusYaritza Peña, Karin Tse, Leslie M Hanrahan, et al.
Pediatric Research|February 8, 2025
Breaking the silence: challenges and opportunities in pediatric drug developmentKanwaljit Singh, Tim Franson, Susan McCune, et al.
The New England Journal of Medicine|April 29, 2005
The cost of institutional review boards in academic medical centersJeremy Sugarman, Kenneth Getz, Jeanne L Speckman, et al.
JMIR AI|June 22, 2026
Patient Perceptions on the Use of Artificial Intelligence in Creating Clinical Research Documents: Survey StudyKimbra Edwards, Samuel Entwisle, Zack Fey, et al.
Therapeutic Innovation & Regulatory Science|June 18, 2020
Benchmarking Patient Recruitment and Retention PracticesMary Jo Lamberti, Zachary Smith, Rhonda Henry, et al.
Therapeutic Innovation & Regulatory Science|December 30, 2025
Insights Informing Strategies for Optimizing the Collection of Clinical Trial DataKenneth Getz, Emily Botto, Ana Calduch Arques, et al.
Journal of Clinical Pharmacology|May 7, 2016
Bridging the Academia/Industry Chasm: Proposed SolutionsPaul Beninger, Marcia Boumil, Deeb Salem, et al.
IRB|September 13, 2007
Determining the costs of Institutional Review BoardsJeanne L Speckman, Margaret M Byrne, Jason Gerson, et al.
Expert Review of Clinical Pharmacology|March 7, 2012
Meeting the obligation to communicate clinical trial results to study volunteersKenneth Getz, Zachary Hallinan, Diane Simmons, et al.
Therapeutic Innovation & Regulatory Science|May 2, 2018
Assessing the Financial Value of Patient Engagement: A Quantitative Approach from CTTI's Patient Groups and Clinical Trials ProjectBennett Levitan, Kenneth Getz, Eric L Eisenstein, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Therapeutic Innovation & Regulatory Science|September 1, 2020
Establishing Consensus Understanding of the Barriers to Drug Development in LupusYaritza Peña, Karin Tse, Leslie M Hanrahan, et al.
Pediatric Research|February 8, 2025
Breaking the silence: challenges and opportunities in pediatric drug developmentKanwaljit Singh, Tim Franson, Susan McCune, et al.
The New England Journal of Medicine|April 29, 2005
The cost of institutional review boards in academic medical centersJeremy Sugarman, Kenneth Getz, Jeanne L Speckman, et al.
JMIR AI|June 22, 2026
Patient Perceptions on the Use of Artificial Intelligence in Creating Clinical Research Documents: Survey StudyKimbra Edwards, Samuel Entwisle, Zack Fey, et al.
Therapeutic Innovation & Regulatory Science|June 18, 2020
Benchmarking Patient Recruitment and Retention PracticesMary Jo Lamberti, Zachary Smith, Rhonda Henry, et al.
Therapeutic Innovation & Regulatory Science|December 30, 2025
Insights Informing Strategies for Optimizing the Collection of Clinical Trial DataKenneth Getz, Emily Botto, Ana Calduch Arques, et al.
Journal of Clinical Pharmacology|May 7, 2016
Bridging the Academia/Industry Chasm: Proposed SolutionsPaul Beninger, Marcia Boumil, Deeb Salem, et al.
IRB|September 13, 2007
Determining the costs of Institutional Review BoardsJeanne L Speckman, Margaret M Byrne, Jason Gerson, et al.
Expert Review of Clinical Pharmacology|March 7, 2012
Meeting the obligation to communicate clinical trial results to study volunteersKenneth Getz, Zachary Hallinan, Diane Simmons, et al.
Therapeutic Innovation & Regulatory Science|May 2, 2018
Assessing the Financial Value of Patient Engagement: A Quantitative Approach from CTTI's Patient Groups and Clinical Trials ProjectBennett Levitan, Kenneth Getz, Eric L Eisenstein, et al.
Pageof 6